Recap: Champions Oncology Q2 Earnings

Champions Oncology CSBR reported its Q2 earnings results on Tuesday, December 12, 2023 at 04:00 PM.

Here's what investors need to know about the announcement.

Champions Oncology beat estimated earnings by 11.76%, reporting an EPS of $-0.15 versus an estimate of $-0.17.

Revenue was down $2.71 million from the same period last year.

Last quarter the company missed on EPS by $0.06 which was followed by a 1.45% drop in the share price the next day.

Here's a look at Champions Oncology's past performance:

Quarter	Q1 2024	Q4 2023	Q3 2023	Q2 2023
EPS Estimate	-0.10	-0.12	-0.03	-0.01
EPS Actual	-0.16	-0.17	-0.16	0.01
Revenue Estimate	13.06M	12.86M	13.13M	13.79M
Revenue Actual	12.56M	13.07M	12.77M	14.28M

To track all earnings releases for Champions Oncology visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar